dr. reddy's labs glp-1 receptor agonist medications Dr Gets SEC Nod to Manufacture, Market Oral Semaglutide Tablets With the launch of Obeda®,

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Two of the most popular bariatric procedures, vertical sleeve gastrectomy (VSG) and Roux-en-Y gastric bypass (RYGB), are commonly considered metabolic surgeries because they are thought to affect metabolism in a weight lossindependent manner

Working with George Karavetsos, former director of FDA's Office of Criminal...

Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions